Home＜ Investor Relations

Investor Relations

Company Profile Corporate Governance
Information Disclosure
Announcements and Circulars Financial Reports and ESG Reports The Listed Files
Presentations & Webcasts Investor Relations Query
2022.12
07

FORM OF PROXY

2022.12
06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022

2022.12
02

FURTHER DELAY IN DISPATCH OF CIRCULAR IN RESPECT OF CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE TO TRUSTEE HOLDING SHARES ON TRUST FOR CONNECTED PERSON AND CLOSURE OF REGISTER OF MEMBERS FOR EXTRAORDINARY GENERAL MEETING

2022.11
24

DELAY IN DISPATCH OF CIRCULAR IN RESPECT OF CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE TO TRUSTEE HOLDING SHARES ON TRUST FOR CONNECTED PERSONS (

2022.11
09

CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022

2022.11
03

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022

2022.11
01

(1) GRANT OF AWARD SHARES UNDER RESTRICTED SHARE AWARD SCHEME (

2022.10
25

VOLUNTARY ANNOUNCEMENT - SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES

2022.10
07

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022